Biotech · Private company
Wockhardt
Track this companyFree. Adds Wockhardt to your Dealase workspace and tells you when its record changes.
Clinical trials80 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline14
- Cefepime-zidebactam (FEP-ZID)Phase 3 · Complicated Urinary Tract InfectionClinicalTrials.gov · fetched Nov 12, 2026
- MeropenemPhase 3 · Complicated Urinary Tract InfectionClinicalTrials.gov · fetched Nov 12, 2026
- Novolin® (N or 70/30 with R)Phase 3 · Type I DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Wosulin (N or 70/30 with R)Phase 3 · Type I DiabetesClinicalTrials.gov · fetched Nov 12, 2026
- Moxifloxacin 400 mgPhase 2 · Community-Acquired Bacterial Pneumonia (CABP)ClinicalTrials.gov · fetched Nov 12, 2026
- Nafithromycin 800 mg 3 daysPhase 2 · Community-Acquired Bacterial Pneumonia (CABP)ClinicalTrials.gov · fetched Nov 12, 2026
- Nafithromycin 800 mg 5 daysPhase 2 · Community-Acquired Bacterial Pneumonia (CABP)ClinicalTrials.gov · fetched Nov 12, 2026
- 3 g or 6 g ZidebactamPhase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- FEP-ZIDPhase 1 · PHA1AClinicalTrials.gov · fetched Nov 12, 2026
- MetronidazolePhase 1 · PHA1AClinicalTrials.gov · fetched Nov 12, 2026
- NafithromycinPhase 1 · HealthyClinicalTrials.gov · fetched Nov 12, 2026
- WCK 771 IV InfusionPhase 1 · BioavailabilityClinicalTrials.gov · fetched Nov 12, 2026
- zidebactam administered as a 1g (approximately 200 μCi) IV infusion over 1 hourPhase 1 · Healthy Subjects (HS)ClinicalTrials.gov · fetched Nov 12, 2026
- Zidebactam-CefepimePhase 1 · PHA1AClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- A Single-center, Open-label, Study Evaluating Safety and Pharmacokinetics of Single Doses of Zidebactam-Cefepime and Metronidazole Alone or in Combination.PHASE1 · COMPLETED · started Jan 21, 2025ClinicalTrials.gov NCT06806995 · fetched Nov 12, 2026
- Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)PHASE3 · COMPLETED · started Aug 28, 2022ClinicalTrials.gov NCT04979806 · fetched Nov 12, 2026
- Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Intravenous NafithromycinPHASE1 · COMPLETED · started Jun 18, 2019ClinicalTrials.gov NCT03981887 · fetched Nov 12, 2026
- Study of the Metabolism and Excretion of Zidebactam (WCK 5107) Following a Single Intravenous Infusion.PHASE1 · COMPLETED · started Dec 13, 2017ClinicalTrials.gov NCT07247942 · fetched Nov 12, 2026
- Phase II Study of Oral Nafithromycin in CABPPHASE2 · COMPLETED · started Nov 18, 2016ClinicalTrials.gov NCT02903836 · fetched Nov 12, 2026
- MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Intravenous Zidebactam in Healthy AdultsPHASE1 · COMPLETED · started Feb 1, 2016ClinicalTrials.gov NCT02674347 · fetched Nov 12, 2026
- Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Intravenous WCK 771PHASE1 · COMPLETED · started Dec 1, 2011ClinicalTrials.gov NCT05640531 · fetched Nov 12, 2026
- Immunosafety Study of Recombinant Human Insulins in Type 1 DiabeticsPHASE3 · TERMINATED · started Mar 1, 2011ClinicalTrials.gov NCT01308437 · fetched Nov 12, 2026